WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 33  33  33  32  32  27  24  21 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years

Number of reported cases

(Click for retrospective incidence data for San Marino)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
 
Mumps
ChartChart
  11 
Pertussis
ChartChart
  13 
Polio*
ChartChart
 
Rubella
ChartChart
  11 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for San Marino)
Vaccine year result method % card seen                                                
BCG         
DTP1          78  77  82  72  88  97 
DTP3          66  76  80  69  96  96 
DTP4          77  79  75 
IPV1          78  77  82 
HepB_BD         
HepB3          66  75  80  69  96  94 
Hib3          65  79  69  96  92 
JapEnc         
MCV1          62  53  57  74  87  74 
MCV2          36  82  76  77  88 
MenA         
PCV1          38 
PCV2          33 
PCV3          13 
Pol3          66  76  80  96  96 
Rota1         
RotaC         
RCV1          62  53  57  74  87 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for San Marino)
DTP1
ChartChart
  78  77  82  72  98  97  99 
DTP3
ChartChart
  66  76  80  69  96  96  99 
HepB3
ChartChart
  66  75  80  69  96  94 
HepB_BD
ChartChart
 
Hib3
ChartChart
  65  75  79  69  96  92 
MCV1
ChartChart
  62  53  57  74  87  74 
MCV2
ChartChart
  36  82  76  77  88 
PCV3
ChartChart
  12 
Pol3
ChartChart
  66  76  80  69  96  96  99 
RCV1
ChartChart
  62  53  57  74  87  74 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
CHOLERA Yes travelers
DTaPHibHepIPV 3, 5, 11 months; Yes
DTaPIPV 6 years; Yes
HepA_Pediatric Yes travelers and risk groups
HepB_Adult Yes risk groups
HepB_Pediatric birth; Yes risk groups
HIB Yes risk groups
HPV 11 years; (x2) Yes
Influenza_Adult Yes adults with chronic illness, and health care workers
Influenza_Pediatric Yes children with chronic diseases
IPV Yes travelers to endemic countries
MenACWY-135 conj 13 months; 13 years; Yes From September 2017 & also risk groups
MenB 4, 5, 6, 12 months; Yes from 2017
MenC_conj 13 months;
MMR 15 months; 10 years; Yes
MMRV 15 months; 10 years; Yes From September 2017
Pneumo_conj 3, 5, 11 months; Yes also risk groups
Pneumo_ps Yes risk groups
Rabies Yes travelers
Rubella Yes risk groups
Td Yes every 10 years
Tdap 14 years; Yes From May 2017
TT Yes every 10 years
Typhoid Yes travelers
Varicella 15 months; 10 years; Yes risk groups

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  No  No  No  No  No  No 
What years does the MYP cover? number 2017-2019             
Nº of districts with microplans that include activities to raise immunization coverage number            

System performance

Total Nº districts in country number        
Nº districts with DTP3 coverage >=80% number          
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number          
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes    No         
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes    No         

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%     100         

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.